TCL Archive Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation April 28, 2006
TCL Archive Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990 January 27, 1989
TCL Archive BCF Members Miffed When NCI Refuses To Delay New Breast Cancer RFA To Allow Them Chance To Study It April 8, 1983
